|
顯示項目 708016-708040 / 2348487 (共93940頁)
<< < 28316 28317 28318 28319 28320 28321 28322 28323 28324 28325 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-06-24T07:16:25Z |
Randomized open trial comparing 2-dose regimens of the human papillomavirus 16/18 as04-adjuvanted vaccine in girls aged 9-14 years versus a 3-dose regimen in women aged 15-25 years
|
Puthanakit T.; LI-MIN HUANG; Chiu C.-H.; Tang R.-B.; Schwarz T.F.; Esposito S.; Frenette L.; Giaquinto C.; McNeil S.; Rheault P.; Durando P.; Horn M.; Klar M.; Poncelet S.; De Simoni S.; Friel D.; De Muynck B.; Suryakiran P.V.; Hezareh M.; Descamps D.; Thomas F.; Struyf F. |
| 國家衛生研究院 |
2014-05 |
Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally ad
|
Denlinger, CS;Sym, SJ;Bendell, JC;Alsina, M;Watkins, D;Chao, Y;Cubillo, A;Kunz, PL;Sun, WJ;Baeksgaard, L;Chen, LT;Horgan, K;Frye, S;Kudia, AJ;McDonagh, CF;Czibere, AG;Moyo, VM;Chibaudel, B;Bang, YJ |
| 國立成功大學 |
2016-08 |
Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma
|
Abou-Alfa, Ghassan K.;Puig, Oscar;Daniele, Bruno;Kudo, Masatoshi;Merle, Philippe;Park, Joong-Won;Ross, Paul;Peron, Jean-Marie;Ebert, Oliver;Chan, Stephen;Poon, Tung Ping;Colombo, Massimo;Okusaka, Takuji;Ryoo, Baek-Yeol;Minguez, Beatriz;Tanaka, Takayoshi;Ohtomo, Toshihiko;Ukrainskyj, Stacey;Boisserie, Frederic;Rutman, Olga;Chen, Ya-Chi;Xu, Chao;Shochat, Eliezer;Jukofsky, Lori;Reis, Bernhard;Chen, Gong;Di Laurenzio, Laura;Lee, Ray;Yen, Chia-Jui |
| 國家衛生研究院 |
2011-02 |
Randomized phase II study of PEP02, irinotecan, or docetaxel as a second-line therapy in gastric or gastroesophageal junction adenocarcinoma
|
Cunningham, D;Park, S;Kang, Y;Chao, Y;Chen, L;Rees, C;Lim, H;Tabernero, J;Yeh, G;De Gramont, A |
| 臺大學術典藏 |
2020-05-26T09:27:06Z |
Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer
|
Orlando M.;Linn C;Peng G;Blair J.M;Chen Y.-M;Xiu Q;Kang J.-H;Liang J;Chih-Hsin Yang;Ahn M.-J; Ahn M.-J; CHIH-HSIN YANG; Liang J; Kang J.-H; Xiu Q; Chen Y.-M; Blair J.M; Peng G; Linn C; Orlando M. |
| 臺大學術典藏 |
2020-05-26T09:26:44Z |
Randomized phase II trial of gefitinib with and without pemetrexed as first-line therapy in patients with advanced nonsquamous non-small-cell lung cancer with activating epidermal growth factor receptor mutations
|
Chih-Hsin Yang;Orlando M;Puri T;Enatsu S;Wang X;Kim J.-H;Kang J.H;Nakagawa K;He J;Yang P.-C;Murakami H;Cheng Y; Cheng Y; Murakami H; Yang P.-C; He J; Nakagawa K; Kang J.H; Kim J.-H; Wang X; Enatsu S; Puri T; Orlando M; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-12-02T02:33:19Z |
Randomized phase II trial of gefitinib with and without pemetrexed as first-line therapy in patients with advanced nonsquamous non-small-cell lung cancer with activating epidermal growth factor receptor mutations
|
Cheng Y.; Murakami H.; Pan-Chyr Yang; He J.; Nakagawa K.; Kang J.H.; Kim J.-H.; Wang X.; Enatsu S.; Puri T.; Orlando M.; Yang J.C.-H.; Cheng Y.; PAN-CHYR YANG et al. |
| 國家衛生研究院 |
2012-05-20 |
Randomized phase II trial of TACE plus everolimus as first-line therapy in localized unresectable hepatocellular carcinoma (HCC): The TRACER trial
|
Poon, RTP;Chen, LT;Xue, HL;Tannir, B;Wang, JH;Tanwandee, T;Paik, SW |
| 國立成功大學 |
2007 |
Randomized phase II trial of thalidomide alone versus thalidomide plus interferon alpha in patients with refractory multiple myeloma
|
Chiou, Tzeon-Jye; Wang, Teng-Hsu; Chao, Tsu-Yi; Lin, Sheng-Fung; Tang, Jih-Luh; Chen, Tsai-Yun; Chang, Ming-Chih; Hsueh, Erh-Jung; Chen, Po-Min |
| 國立臺灣大學 |
2007 |
Randomized Phase Ii Trial of Thalidomide Alone Versus Thalidomide Plus Interferon Alpha in Patients with Refractory Multiple Myeloma
|
邱宗傑; 趙祖怡; 林勝豐; 唐季祿; 陳彩雲; 張明志; 薛爾榮; 陳博明; CHIOU, TZEON-JYE; CHAO, TSU-YI; LIN, SHENG-FONG; TANG, JIH-LUH; CHEN, TSAI-YUN; CHANG, MING-CHIH; HSUEH, ERH-JUNG; CHEN, PO-MIN |
| 臺大學術典藏 |
2021-01-06T03:58:49Z |
Randomized phase II trial of thalidomide alone versus thalidomide plus interferon alpha in patients with refractory multiple myeloma
|
Chiou T.-J.; Wang T.-H.; Chao T.-Y.; Lin S.-F.; JIH-LUH TANG; Chen T.-Y.; Chang M.-C.; Hsueh E.-J.; Chen P.-M. |
| 臺大學術典藏 |
2021-02-19T06:52:26Z |
Randomized phase III KEYNOTE-181 study of pembrolizumab versus chemotherapy in advanced esophageal cancer
|
Kojima T.;Shah M.A.;Muro K.;Francois E.;Adenis A.;Chih-Hung Hsu;Doi T.;Moriwaki T.;Kim S.-B.;Lee S.-H.;Bennouna J.;Kato K.;Shen L.;Enzinger P.;Qin S.-K.;Ferreira P.;Chen J.;Girotto G.;De La Fouchardiere C.;Senellart H.;Al-Rajabi R.;Lordick F.;Wang R.;Suryawanshi S.;Bhagia P.;Peter Kang S.;Metges J.-P.;Keynote-181 Investigators; Kojima T.; Shah M.A.; Muro K.; Francois E.; Adenis A.; CHIH-HUNG HSU; Doi T.; Moriwaki T.; Kim S.-B.; Lee S.-H.; Bennouna J.; Kato K.; Shen L.; Enzinger P.; Qin S.-K.; Ferreira P.; Chen J.; Girotto G.; de la Fouchardiere C.; Senellart H.; Al-Rajabi R.; Lordick F.; Wang R.; Suryawanshi S.; Bhagia P.; Peter Kang S.; Metges J.-P.; KEYNOTE-181 Investigators |
| 臺大學術典藏 |
2021-01-12T12:53:45Z |
Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma
|
Spicka I.; Ocio E.M.; Oakervee H.E.; Greil R.; Banh R.H.; SHANG-YI HUANG; D?�Rozario J.M.; Dimopoulos M.A.; Martínez S.; Extremera S.; Kahatt C.; Alfaro V.; Carella A.M.; Meuleman N.; Hájek R.; Symeonidis A.; Min C.-K.; Cannell P.; Ludwig H.; Sonneveld P.; Mateos M.V. |
| 國立臺灣大學 |
2005 |
Randomized Phase Iii Study of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma with Curative Resection - the Taiwan Cooperative Oncology Group (Tcog T1297) Study
|
李伯皇; 鄭隆賓; 陳培哲; LEE, PO-HUANG; JENG, LONG-BIN; CHEN, PEI- JER |
| 國立臺灣大學 |
2005-10 |
Randomized phase III study of adjuvant interferon alfa-2B in hepatocellular carcinoma with curative resection - The Taiwan cooperative oncology group (TCOG T1297) study
|
Chen, LT; Chen, MF; Lee, LA; Lee, PH; Jeng, LB; Lin, DY; Wu, CC; Mok, KT; Chen, CL; Lee, WC; Chau, GY; Chen, YS; Lui, WY; Chen, PJ |
| 國立成功大學 |
2018 |
Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer
|
Gerber, D.E.;Horn, L.;Boyer, M.;Sanborn, R.;Natale, R.;Palmero, R.;Bidoli, P.;Bondarenko, I.;Germonpre, P.;Ghizdavescu, D.;Kotsakis, A.;Lena, H.;Losonczy, G.;Park, K.;Su, W.-C.;Tang, M.;Lai, J.;Kallinteris, N.L.;Shan, J.S.;Reck, M.;Spigel, D.R. |
| 國立臺灣大學 |
2013 |
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|
Ueno, Hideki; Ioka, Tatsuya; Ikeda, Masafumi; Ohkawa, Shinichi; Yanagimoto, Hiroaki; Boku, Narikazu; Fukutomi, Akira; Sugimori, Kazuya; Baba, Hideo; Yamao, Kenji; Shimamura, Tomotaka; Sho, Masayuki; Kitano, Masayuki; Cheng, Ann-Lii; Mizumoto, Kazuhiro; Chen, Jen-Shi; Furuse, Junji; Funakoshi, Akihiro; Hatori, Takashi; Yamaguchi, Taketo; Egawa, Shinichi; Sato, Atsushi; Ohashi, Yasuo; Okusaka, Takuji; Tanaka, Masao; 鄭安理 |
| 臺大學術典藏 |
2021-09-01T01:53:48Z |
Randomized phase iii study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: Gest study
|
Ueno H.; Ioka T.; Ikeda M.; Ohkawa S.; Yanagimoto H.; Boku N.; Fukutomi A.; Sugimori K.; Baba H.; Yamao K.; Shimamura T.; Sho M.; Kitano M.; ANN-LII CHENG; Mizumoto K.; Chen J.-S.; Furuse J.; Funakoshi A.; Hatori T.; Yamaguchi T.; Egawa S.; Sato A.; Ohashi Y.; Okusaka T.; Tanaka M. |
| 國立臺灣大學 |
2015 |
Randomized Phase III trial of afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one prior trastuzumab treatment: LUX-Breast 1
|
Harbeck, Nadia; Huang, Chiun-Sheng; Hurvitz, Sara; Yeh, Dah-Cherng; Shao, Zhimin; Im, Seock-Ah; Jung, Kyung Hae; Shen, Kunwei; Ro, Jungsil; Jassem, Jacek; Zhang, Qingyuan; Im, Young-Hyuck; Wojtukiewicz, Marek; Sun, Qiang; Chen, Shin-Cheh; Goeldner, Rainer-Georg; Lahogue, Annick; Uttenreuther-Fischer, Martina; Xu, Binghe; Piccart-Gebhart, Martine; 黃俊升 |
| 中山醫學大學 |
2006 |
Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr
|
Chen, S.-T.;Lu, K.-H.;Sun, H.-L.;Chang, W.-T.;Lue, K.-H.;Chou, M.-C. |
| 中山醫學大學 |
2006-02 |
Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr.
|
Chen ST; Lu KH; Sun HL; Chang WT; Lue KH; Chou MC |
| 國立交通大學 |
2014-12-08T15:07:20Z |
RANDOMIZED POLICY OF A POISSON INPUT QUEUE WITH J VACATIONS
|
Ke, Jau-Chuan; Huang, Kai-Bin; Pearn, Wen Lea |
| 國立臺灣科技大學 |
2012 |
Randomized search strategy for unstructured P2P networks
|
Chen, W.-M.;Liu, K.-C. |
| 國立臺灣大學 |
2011 |
Randomized Spectrum Access in Cognitive Radio Networks with a Large Number of Cognitive Users
|
Hsu, Fu-Te; Su, Hsuan-Jung |
| 臺大學術典藏 |
2020-06-16T06:41:51Z |
Randomized spectrum access in cognitive radio networks with a large number of cognitive users
|
Hsu, F.-T.;Su, H.-J.; Hsu, F.-T.; Su, H.-J.; HSUAN-JUNG SU |
顯示項目 708016-708040 / 2348487 (共93940頁)
<< < 28316 28317 28318 28319 28320 28321 28322 28323 28324 28325 > >>
每頁顯示[10|25|50]項目
|
